Literature DB >> 10447219

Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway.

H E Kim1, J H Oh, S K Lee, Y J Oh.   

Abstract

We used the rat C6 gliomal cell line to investigate the potential role of ginsenoside Rh2 (G-Rh2) in brain tumor. G-Rh2 induced many apoptotic manifestations in C6 gliomal cells as evidenced by changes in cell morphology, generation of DNA fragmentation, activation of caspase and production of reactive oxygen species (ROS). As a result, cotreatment with antioxidants or a broad-spectrum caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone effectively attenuated G-Rh2-induced cell death. However, specific cleavage of poly(ADP-ribose)polymerase into 85 kDa protein was not detected as demonstrated in many other apoptotic paradigms. Expression levels of Bcl-2 and Bax remained unchanged following G-Rh2 treatment. Furthermore, G-Rh2-induced cell death in C6 gliomal cells overexpressing antiapoptotic protein, Bcl-X(L), was comparable to that in parental cells. Taken together, our data indicate that G-Rh2-induced cell death is mediated by the generated ROS and the activation of caspase pathway in a Bcl-X(L)-independent manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447219     DOI: 10.1016/s0024-3205(99)00252-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Ginsenoside Rh2 inhibits glioma cell proliferation by targeting microRNA-128.

Authors:  Nan Wu; Guo-cai Wu; Rong Hu; Mei Li; Hua Feng
Journal:  Acta Pharmacol Sin       Date:  2011-03       Impact factor: 6.150

2.  Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides.

Authors:  Soyong Jang; Jong Hoon Ryu; Dong-Hyun Kim; Seikwan Oh
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

3.  Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury.

Authors:  Yong Cheol Ji; Young Baeg Kim; Seung Won Park; Sung Nam Hwang; Byung Kook Min; Hyun Jong Hong; Jeong Taik Kwon; Jong Sik Suk
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

4.  Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).

Authors:  M Tatsuka; M Maeda; T Ota
Journal:  Jpn J Cancer Res       Date:  2001-11

5.  Ginsenoside Rh2 induces human hepatoma cell apoptosisvia bax/bak triggered cytochrome C release and caspase-9/caspase-8 activation.

Authors:  Xiao-Xi Guo; Qiao Guo; Yang Li; Seung Ki Lee; Xue-Ning Wei; Ying-Hua Jin
Journal:  Int J Mol Sci       Date:  2012-11-22       Impact factor: 5.923

6.  Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides.

Authors:  Patrick Ying Kit Yue; Nai Ki Mak; Yuen Kit Cheng; Kar Wah Leung; Tzi Bun Ng; David Tai Ping Fan; Hin Wing Yeung; Ricky Ngok Shun Wong
Journal:  Chin Med       Date:  2007-05-15       Impact factor: 5.455

7.  Ginsenoside compound K induces apoptosis in nasopharyngeal carcinoma cells via activation of apoptosis-inducing factor.

Authors:  Carmen Ka-Man Law; Hoi-Hin Kwok; Po-Ying Poon; Chi-Chiu Lau; Zhi-Hong Jiang; William Chi-Shing Tai; Wendy Wen-Luan Hsiao; Nai-Ki Mak; Patrick Ying-Kit Yue; Ricky Ngok-Shun Wong
Journal:  Chin Med       Date:  2014-04-02       Impact factor: 5.455

Review 8.  Role of ginsenosides in reactive oxygen species-mediated anticancer therapy.

Authors:  Islam M D Sodrul; Chenying Wang; Xiangfeng Chen; Jing Du; Hongxiang Sun
Journal:  Oncotarget       Date:  2017-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.